- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00004350
Evaluation of Fanconi Syndrome and Cystinosis
June 23, 2005 updated by: National Center for Research Resources (NCRR)
OBJECTIVES:
I. Classify renal tubular defects using clinical and biochemical findings in patients with Fanconi syndrome and cystinosis.
Study Overview
Status
Completed
Conditions
Detailed Description
PROTOCOL OUTLINE:
Patients receive a clinical and biochemical evaluation, including a psychometric assessment and molecular, renal, and thyroid studies.
Study Type
Observational
Enrollment
12
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 second and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
- Inherited renal tubular defects, i.e., Fanconi syndrome
- Fanconi syndrome due to cystinosis eligible
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Study Chair: Jerry A. Schneider, University of California, San Diego
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 1999
Study Registration Dates
First Submitted
October 18, 1999
First Submitted That Met QC Criteria
October 18, 1999
First Posted (Estimate)
October 19, 1999
Study Record Updates
Last Update Posted (Estimate)
June 24, 2005
Last Update Submitted That Met QC Criteria
June 23, 2005
Last Verified
December 1, 1999
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Metabolic Diseases
- Kidney Diseases
- Urologic Diseases
- Disease
- Bone Marrow Diseases
- Hematologic Diseases
- Genetic Diseases, Inborn
- Anemia
- Metabolism, Inborn Errors
- Lysosomal Storage Diseases
- DNA Repair-Deficiency Disorders
- Anemia, Hypoplastic, Congenital
- Anemia, Aplastic
- Congenital Bone Marrow Failure Syndromes
- Bone Marrow Failure Disorders
- Renal Tubular Transport, Inborn Errors
- Syndrome
- Fanconi Syndrome
- Fanconi Anemia
- Cystinosis
Other Study ID Numbers
- 199/11911
- UCSD-012
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fanconi Syndrome
-
Cystinosis Research FoundationUnknownCystinosis | Nephropathic Cystinosis | Renal Fanconi SyndromeUnited States
-
Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of Medicine; University of...TerminatedFANCONI ANEMIAUnited States
-
Rocket Pharmaceuticals Inc.Active, not recruitingFanconi Anemia Complementation Group ASpain
-
Rocket Pharmaceuticals Inc.UnknownFanconi Anemia Complementation Group AUnited States
-
Rocket Pharmaceuticals Inc.Enrolling by invitationFanconi Anemia | Fanconi Anemia Complementation Group ASpain
-
CENTOGENE GmbH RostockWithdrawnHypophosphatemia | Photophobia | Renal Fanconi SyndromeGermany, India, Sri Lanka
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...CompletedPreviously Treated Myelodysplastic Syndrome | Fanconi Anemia | de Novo Myelodysplastic Syndrome | Acute Myeloid Leukemia in RemissionUnited States, Brazil
-
Rocket Pharmaceuticals Inc.Active, not recruitingFanconi Anemia Complementation Group AUnited States
-
Masonic Cancer Center, University of MinnesotaCompleted
-
Masonic Cancer Center, University of MinnesotaTerminated